EP3310363A4 - Antimicrobial formulations - Google Patents

Antimicrobial formulations Download PDF

Info

Publication number: EP3310363A4
Authority: EP; European Patent Office
Prior art keywords: antimicrobial formulations; antimicrobial; formulations
Prior art date: 2015-06-18
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Pending

Application number

EP16812480.8A

Other languages

German (de)

French (fr)

Other versions

EP3310363A1 (en

Inventor

Bahram Memarzadeh

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Common Pharma Inc

Original Assignee

Common Pharma Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2015-06-18

Filing date

2016-06-17

Publication date

2019-02-13

2016-06-17 Application filed by Common Pharma Inc filed Critical Common Pharma Inc

2018-04-25 Publication of EP3310363A1 publication Critical patent/EP3310363A1/en

2019-02-13 Publication of EP3310363A4 publication Critical patent/EP3310363A4/en

Status Pending legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/22—Boron compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Epidemiology (AREA)
Inorganic Chemistry (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Dispersion Chemistry (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

EP16812480.8A 2015-06-18 2016-06-17 Antimicrobial formulations Pending EP3310363A4 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US201562181202P	2015-06-18	2015-06-18
PCT/US2016/037947 WO2016205574A1 (en)	2015-06-18	2016-06-17	Antimicrobial formulations

Publications (2)

Publication Number	Publication Date
EP3310363A1 EP3310363A1 (en)	2018-04-25
EP3310363A4 true EP3310363A4 (en)	2019-02-13

Family

ID=57546223

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP16812480.8A Pending EP3310363A4 (en)	2015-06-18	2016-06-17	Antimicrobial formulations

Country Status (3)

Country	Link
EP (1)	EP3310363A4 (en)
CN (1)	CN108367026A (en)
WO (1)	WO2016205574A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR20210031466A (en) *	2018-06-13	2021-03-19	교토 바이오파마 세야쿠 가부시키가이샤	Enhancement of antibacterial activity of depsipeptide antibiotics using synergistic boric acid
TR201903211A2 (en) *	2019-03-04	2019-03-21	Kahramanmaras Suetcue Imam Ueniversitesi	DRINKABLE BORON SOLUTION

Citations (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2000024425A1 (en) *	1998-10-27	2000-05-04	Alcon Laboratories, Inc.	Preservative system for topically administrable pharmaceutical compositions
WO2001019366A1 (en) *	1999-09-13	2001-03-22	Insite Vision Incorporated	Topical treatment for prevention of ocular infections
CN1895218A (en) *	2006-06-22	2007-01-17	武汉远大制药集团有限公司	Pyrrolechrisxi and its sodium-salt eye-gel preparation and its making method
CN1895219A (en) *	2006-06-22	2007-01-17	武汉远大制药集团有限公司	Bendalysine eye gel preparation and its making method
CN1961879A (en) *	2005-11-09	2007-05-16	上海医药工业研究院	Pharmaceutical composition for nose administered in-situ gel spray of Huperzine A, preparation process and use thereof
CN1981858A (en) *	2005-12-16	2007-06-20	杨伟荣	Baicao gel for treating gynecologic inflammation
US20070298126A1 (en) *	2006-06-22	2007-12-27	Jack Howard Kessler	Method for the eradication of pathogens including S. aureus and antibiotic resistant microbes from the upper respiratory tract of mammals and for inhibiting the activation of immune cells
US20110135743A1 (en) *	2009-12-03	2011-06-09	Alcon Research, Ltd.	Carboxyvinyl polymer-containing nanoparticle suspensions
US20120070401A1 (en) *	2010-09-21	2012-03-22	Jinzhong Zhang	Composition and Method for Promoting Wound Healing
EP2526923A1 (en) *	2009-11-27	2012-11-28	Shenyang Xingqi Pharmaceutical Co., Ltd.	Ophthalmic gel of gatifloxacin and preparation method thereof
US20130177599A1 (en) *	2012-01-06	2013-07-11	Insite Vision Incorporated	Methods and kits for extending contact lens use
WO2014168592A1 (en) *	2013-04-08	2014-10-16	Yeditepe Universitesi	Antiviral gel combination
WO2015070630A1 (en) *	2013-11-18	2015-05-21	中国医学科学院生物医学工程研究所	Use of new type of anti-hpv pharmaceutical preparation

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5853767A (en) *	1997-01-02	1998-12-29	Melman; Steven A.	Compositions for treating fungal, parasitic and/or bacterial infections, especially infections of organs such as the skin and vagina
GEP20074224B (en) *	2002-12-18	2007-10-25	Ferrer Int	Pharmaceutical compositions of sertaconazole for vaginal use
KR20110098863A (en) *	2003-06-13	2011-09-01	알콘, 인코퍼레이티드	Ophthalmic compositions containing a synergistic combination of two polymers
US7914803B2 (en) *	2003-06-13	2011-03-29	Alcon, Inc.	Ophthalmic compositions containing a synergistic combination of three polymers
US8722123B2 (en) *	2008-05-22	2014-05-13	University Of Georgia Research Foundation, Inc.	Antimicrobial composition and use as food treatment
US9248159B2 (en) *	2008-10-14	2016-02-02	Robert Stanley Berman	MRSA bactericidal topical gel
EP2630952A1 (en) *	2012-02-23	2013-08-28	Novagali Pharma S.A.	Self-preserved oil dispersions comprising boric acid
CN105362289B (en) *	2015-10-24	2018-08-31	惠峪	A kind of vaginal retention borate compounds and preparation method thereof

2016
- 2016-06-17 WO PCT/US2016/037947 patent/WO2016205574A1/en active Application Filing
- 2016-06-17 CN CN201680046713.9A patent/CN108367026A/en active Pending
- 2016-06-17 EP EP16812480.8A patent/EP3310363A4/en active Pending

Patent Citations (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2000024425A1 (en) *	1998-10-27	2000-05-04	Alcon Laboratories, Inc.	Preservative system for topically administrable pharmaceutical compositions
WO2001019366A1 (en) *	1999-09-13	2001-03-22	Insite Vision Incorporated	Topical treatment for prevention of ocular infections
CN1961879A (en) *	2005-11-09	2007-05-16	上海医药工业研究院	Pharmaceutical composition for nose administered in-situ gel spray of Huperzine A, preparation process and use thereof
CN1981858A (en) *	2005-12-16	2007-06-20	杨伟荣	Baicao gel for treating gynecologic inflammation
US20070298126A1 (en) *	2006-06-22	2007-12-27	Jack Howard Kessler	Method for the eradication of pathogens including S. aureus and antibiotic resistant microbes from the upper respiratory tract of mammals and for inhibiting the activation of immune cells
CN1895219A (en) *	2006-06-22	2007-01-17	武汉远大制药集团有限公司	Bendalysine eye gel preparation and its making method
CN1895218A (en) *	2006-06-22	2007-01-17	武汉远大制药集团有限公司	Pyrrolechrisxi and its sodium-salt eye-gel preparation and its making method
EP2526923A1 (en) *	2009-11-27	2012-11-28	Shenyang Xingqi Pharmaceutical Co., Ltd.	Ophthalmic gel of gatifloxacin and preparation method thereof
US20110135743A1 (en) *	2009-12-03	2011-06-09	Alcon Research, Ltd.	Carboxyvinyl polymer-containing nanoparticle suspensions
US20120070401A1 (en) *	2010-09-21	2012-03-22	Jinzhong Zhang	Composition and Method for Promoting Wound Healing
US20130177599A1 (en) *	2012-01-06	2013-07-11	Insite Vision Incorporated	Methods and kits for extending contact lens use
WO2014168592A1 (en) *	2013-04-08	2014-10-16	Yeditepe Universitesi	Antiviral gel combination
WO2015070630A1 (en) *	2013-11-18	2015-05-21	中国医学科学院生物医学工程研究所	Use of new type of anti-hpv pharmaceutical preparation

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2016205574A1 *

Also Published As

Publication number	Publication date
WO2016205574A1 (en)	2016-12-22
EP3310363A1 (en)	2018-04-25
CN108367026A (en)	2018-08-03

Publication	Publication Date	Title
EP3582755A4 (en)	2020-12-23	Formulations
EP3291824A4 (en)	2019-01-23	Antimicrobial therapy
EP3346997A4 (en)	2019-05-15	Bioorthogonal compositions
EP3240555A4 (en)	2018-12-05	Multi-supplement compositions
EP3337502A4 (en)	2019-01-23	Stable anti-ifnar1 formulation
EP3328199A4 (en)	2019-02-27	Antimicrobial compositions and uses thereof
EP3116320A4 (en)	2017-08-16	Botanical antimicrobial compositions
EP3240415A4 (en)	2018-06-13	Fungicidal compositions
AU2016291708B2 (en)	2020-12-24	Plinabulin compositions
EP3484288A4 (en)	2020-01-08	Pesticidal compositions
EP3300502A4 (en)	2019-02-20	Preparation comprising arabinoxylo-oligosaccharides
EP3443078A4 (en)	2020-04-15	Antimicrobial compositions
EP3368012A4 (en)	2019-06-05	Lisinopril formulations
EP3272917A4 (en)	2018-10-24	Antimicrobial fiber
EP3282848A4 (en)	2018-11-21	Agricultural composition
EP3458041A4 (en)	2020-01-15	Antibacterial compositions
EP3397289A4 (en)	2019-06-05	Antimicrobial wipe
EP3288386A4 (en)	2018-10-03	Anti-phytopathogenic compositions
EP3373928A4 (en)	2019-08-07	Novel formulations
EP3349766A4 (en)	2019-05-01	Anti-hemorrhaging compositions
EP3337463A4 (en)	2019-04-03	Pharmaceutical formulations
EP3197479A4 (en)	2017-10-11	Antimicrobial peptides
EP3496714A4 (en)	2020-04-22	Drug compositions
EP3383912A4 (en)	2019-11-06	Topical formulations
EP3310363A4 (en)	2019-02-13	Antimicrobial formulations

Legal Events

Date	Code	Title	Description
2016-12-23	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE
2018-03-23	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
2018-03-23	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE
2018-04-25	17P	Request for examination filed	Effective date: 20180111
2018-04-25	AK	Designated contracting states	Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
2018-04-25	AX	Request for extension of the european patent	Extension state: BA ME
2018-09-26	DAV	Request for validation of the european patent (deleted)
2018-09-26	DAX	Request for extension of the european patent (deleted)
2019-02-13	A4	Supplementary search report drawn up and despatched	Effective date: 20190116
2019-02-13	RIC1	Information provided on ipc code assigned before grant	Ipc: A61K 9/107 20060101ALI20190109BHEP Ipc: A61K 9/06 20060101ALI20190109BHEP Ipc: A61K 47/32 20060101ALI20190109BHEP Ipc: A61K 9/08 20060101AFI20190109BHEP Ipc: A61K 33/22 20060101ALI20190109BHEP
2021-03-05	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: EXAMINATION IS IN PROGRESS
2021-04-07	17Q	First examination report despatched	Effective date: 20210309
2021-09-21	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: EXAMINATION IS IN PROGRESS